Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

sanofi_pasteur_msd

Sanofi Pasteur and MSD end European vaccines partnership

March 8, 2016 Medical Communications, Research and Development, Sales and Marketing MSD, Sanofi Pasteur, Sanofi pasteur msd, vaccines

Sanofi Pasteur and MSD have announced that they will end their joint vaccines operations in Europe, bringing an end to …
News
dr_virginia_jamieson_

Kuros Biosciences re-appoints chief medical officer

March 8, 2016 Medical Communications

Kuros Biosciences has announced the appointment of Dr Virginia Jamieson as chief medical officer and member of the executive board …
Appointment
bms

BMS criticises Scottish regulator over Opdivo skin cancer ‘no’

March 7, 2016 Medical Communications, Research and Development Bristol-Myers Sqibb, NICE, SMC, melanoma, opdivo

Bristol-Myers Squibb says the Scottish Medicines Consortium’s (SMC) decision not to recommend its immunotherapy Opdivo (nivolumab) as a monotherapy for …
News
teva_copy

Teva suffers EpiPen generic setback after FDA rejection

March 4, 2016 Medical Communications, Research and Development FDA, Teva, analphylaxis, approval, auto injector, auto-injector, rejection

The release of Teva Pharmaceuticals generic for the anaphylaxis treatment, EpiPen (epinephrine), is now expected to be severely delayed after …
News
rd_hands

BioMarin reports positive early-stage results for trial drug to treat CLN2 disease

March 4, 2016 Medical Communications

Biotechnology firm BioMarin Pharmaceutical has announced positive results from early stage trial for drug to treat neurodegenerative disease in children.  …
News
merck_logo_blue_rgb

Merck & Pfizer tie-up with Verastem to develop ovarian cancer drug

March 4, 2016 Medical Communications

German drug major Merck along with Pfizer has joined forces with Verastem to develop the trial drug candidate avelumab to …
News
sanofi_logo_vertical_2011_4colors

Sanofi Genzyme present positive Phase 2 results for fatal neuromuscular disease treatment

March 4, 2016 Medical Communications, Research and Development Pompe disease, Sanofi, clinical trial, neuromuscular, phase 2

Sanofi Genzyme, the branch of the French-based pharma company that focuses on diseases difficult to diagnose and treat, have published …
News
magic_bullets_pills

Almost half of US physicians will prescribe more biosimilars, according to survey

March 4, 2016 Medical Communications Obama, US, biosimilar, patent, prescribing

New data published by InCrowd has suggested that US physicians are very amenable to the prescription of biosimilars, with some …
News
ucb_logo_and_chief_executive

UCB targets regulatory filing for its osteoporosis drug in 2016

March 3, 2016 Medical Communications, Research and Development, Sales and Marketing Romosozumab, UCB Pharma, osteoporosis

Belgian drug company UCB says it is looking at a regulatory filing for its trial drug romosozumab to treat osteoporosis …
News
deb_jorn

Valeant company group chairman and executive vice president resigns

March 3, 2016 Medical Communications, Sales and Marketing Valeant, appointed, resignation

In an already troubled week for Valeant Pharmaceuticals, the company has now announced that its group chairman and executive vice …
Appointment
nda_group_appointment

Bill Griffiths joins NDA group as general manager UK

March 2, 2016 Medical Communications NDA Group

Industry veteran Bill Griffiths has joined NDA Group to head up the company’s UK consulting team and NDA’s advisory board.  …
Appointment

LEO Pharma UK/Ireland appoints new dermatology director

March 2, 2016 Medical Communications, Sales and Marketing

LEO Pharma has appointed Michael Hinchy as dermatology director with responsibility for its UK/Ireland affiliate. Michael brings over 16 years …
Appointment
graff_ferring

Ferring names Aaron Graff CEO of US holding company

March 2, 2016 Medical Communications

Swiss fertility treatment company Ferring Pharmaceuticals on Tuesday named Aaron Graff the chief executive of its US unit, Ferring Holding. …
Appointment

Wave expands team with new appointments

March 1, 2016 Medical Communications

Medical education specialist, Wave, has made five new appointments, which the company says reflects the growth in its business over …
Appointment
ucb_logo

New epilepsy drug launches in UK

February 29, 2016 Medical Communications, Research and Development, Sales and Marketing Briviact, UCB Pharma, epilepsy

UCB Pharma’s Briviact (brivaracetam) has been authorised as an add-on treatment for partial onset seizures (POS), with or without secondary …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026